SFM
AXSM icon

Sphera Funds Management’s Axsome Therapeutics AXSM Stock Holding History

Sphera Funds Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-301,000
Closed -$1.69M – 113
2017
Q4 		$1.69M Sell
301,000
-200,000
-40% -$1.01M 0.27% 106
2017
Q3 		$2.78M Hold
501,000
– – 0.5% 65
2017
Q2 		$2.76M Buy
501,000
+100,000
+25% +$419K 0.56% 67
2017
Q1 		$1.56M Buy
+401,000
New +$1.92M 0.4% 80
2016
Q2 		– Sell
-109,069
Closed -$938K – 98
2016
Q1 		$938K Sell
109,069
-110,931
-50% -$1.02M 0.25% 82
2015
Q4 		$2.01M Buy
+220,000
New +$1.94M 0.36% 86

Other funds holding AXSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $46.9M AUM 7.48% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $186M AUM 51.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return